Financial Gravity Asset Management, Inc. Cytokinetics Inc Transaction History

Financial Gravity Asset Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 26, 2024	SELL	$63.75 - $108.06 $63 - $108	-1 Reduced 33.33%	2 $109,000
Q1 2024 May 13, 2024	BUY	$63.75 - $108.06 $191 - $324	3 New	3 $207,000
Q4 2022 Feb 15, 2023	BUY	$35.77 - $51.11 $1,645 - $2,351	46 New	46 $1.35 Million
Q4 2019 Feb 28, 2020	SELL	$7.95 - $11.84 $826 - $1,231	-104 Closed	0 $0
Q1 2019 Apr 19, 2019	SELL	$5.95 - $10.19 $29 - $50	-5 Reduced 4.59%	104 $1,000
Q3 2018 Oct 31, 2018	SELL	$6.4 - $9.85 $38 - $59	-6 Reduced 5.22%	109 $1,000
Q2 2018 Aug 14, 2018	SELL	$6.9 - $9.9 $27 - $39	-4 Reduced 3.36%	115 $1,000
Q1 2018 May 23, 2018	BUY	$7.2 - $10.05 $856 - $1,195	119 New	119 $1,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.92B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.